Free Trial

Intuitive Surgical (ISRG) Competitors

Intuitive Surgical logo
$547.07 -10.09 (-1.81%)
Closing price 04:00 PM Eastern
Extended Trading
$546.16 -0.91 (-0.17%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ISRG vs. ABT, BSX, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE

Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Intuitive Surgical vs.

Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.

In the previous week, Abbott Laboratories had 3 more articles in the media than Intuitive Surgical. MarketBeat recorded 43 mentions for Abbott Laboratories and 40 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.40 beat Intuitive Surgical's score of 1.29 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
29 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Abbott Laboratories
33 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Intuitive Surgical has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.

Intuitive Surgical currently has a consensus price target of $598.95, indicating a potential upside of 7.64%. Abbott Laboratories has a consensus price target of $142.59, indicating a potential upside of 6.51%. Given Intuitive Surgical's higher probable upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
0 Sell rating(s)
5 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.75
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.84

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$8.71B22.88$2.32B$6.8281.59
Abbott Laboratories$42.34B5.50$13.40B$7.7117.36

Intuitive Surgical received 106 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 70.00% of users gave Abbott Laboratories an outperform vote while only 68.88% of users gave Intuitive Surgical an outperform vote.

CompanyUnderperformOutperform
Intuitive SurgicalOutperform Votes
1058
68.88%
Underperform Votes
478
31.12%
Abbott LaboratoriesOutperform Votes
952
70.00%
Underperform Votes
408
30.00%

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Abbott Laboratories has a net margin of 31.95% compared to Intuitive Surgical's net margin of 27.81%. Abbott Laboratories' return on equity of 20.74% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical27.81% 14.55% 12.88%
Abbott Laboratories 31.95%20.74%11.19%

Summary

Abbott Laboratories beats Intuitive Surgical on 10 of the 19 factors compared between the two stocks.

Get Intuitive Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISRG vs. The Competition

MetricIntuitive SurgicalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$199.33B$9.66B$5.40B$8.47B
Dividend YieldN/A1.61%5.22%4.11%
P/E Ratio86.7621.2826.7519.95
Price / Sales22.8866.19393.46114.60
Price / Cash75.9319.6738.2534.62
Price / Book11.995.186.834.58
Net Income$2.32B$284.66M$3.22B$248.19M
7 Day Performance-1.68%1.11%5.26%2.14%
1 Month Performance18.81%6.95%13.27%16.20%
1 Year Performance38.38%-19.48%17.58%7.87%

Intuitive Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ISRG
Intuitive Surgical
4.2751 of 5 stars
$547.07
-1.8%
$598.95
+9.5%
+39.3%$196.08B$8.71B85.3512,100Positive News
ABT
Abbott Laboratories
4.8788 of 5 stars
$135.12
+0.2%
$142.59
+5.5%
+30.9%$235.09B$42.34B17.66115,000News Coverage
Positive News
BSX
Boston Scientific
4.1927 of 5 stars
$106.44
+0.4%
$114.74
+7.8%
+41.3%$157.47B$17.55B85.1545,000Positive News
Options Volume
SYK
Stryker
4.9273 of 5 stars
$393.72
-0.1%
$427.05
+8.5%
+18.1%$150.28B$23.22B50.7451,000Positive News
MDT
Medtronic
4.4819 of 5 stars
$86.84
+0.5%
$96.14
+10.7%
+1.9%$111.38B$33.20B26.4095,000Trending News
Earnings Report
Dividend Increase
Analyst Forecast
Options Volume
BDX
Becton, Dickinson and Company
4.9818 of 5 stars
$176.24
+0.5%
$231.44
+31.3%
-25.5%$50.51B$20.87B29.2877,000Positive News
EW
Edwards Lifesciences
3.8882 of 5 stars
$77.81
-0.2%
$79.60
+2.3%
-13.3%$45.64B$5.52B11.1617,300Positive News
IDXX
IDEXX Laboratories
3.4005 of 5 stars
$519.65
+0.3%
$536.00
+3.1%
-2.4%$41.79B$3.93B48.7010,800Positive News
Analyst Forecast
RMD
ResMed
4.1302 of 5 stars
$252.02
+0.1%
$258.83
+2.7%
+13.4%$36.95B$5.02B29.758,160News Coverage
Positive News
Analyst Revision
DXCM
DexCom
4.7386 of 5 stars
$86.71
+1.4%
$98.11
+13.1%
-33.2%$34.00B$4.15B60.647,600Positive News
STE
STERIS
4.5625 of 5 stars
$251.98
+0.2%
$264.00
+4.8%
+7.6%$24.76B$5.40B53.5016,000News Coverage
Earnings Report
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:ISRG) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners